Welcome to Accelera, the Contract Research Organization (CRO) of choice as a Drug Development Partner for pharmaceutical and biotechnology companies around the world.

Accelera is committed to supporting all stages of drug discovery and development by offering tailored services spanning multiple disciplines, including early formulation development, preclinical profiling, drug safety, metabolism, bioanalysis and pharmacokinetics (PK).

At Accelera, a unique platform of integrated scientific, technological and regulatory expertise is available to sponsors and partners, built on decades as part of the international pharmaceutical industry.

By predicting and managing potential toxic, pharmacokinetic and metabolic issues, Accelera can truly add value to your discovery and development programs.

Accelera is an independent company within the Nerviano Medical Sciences Group.

With Accelera, Experience Results.